Cargando…
MON-453 Dramatic Clinical Response to Lenvatinib in a Pediatric Patient with Advanced Metastatic Papillary Thyroid Carcinoma
Introduction: Papillary thyroid cancer (PTC) is the most common thyroid tumor in childhood. Most patients are referred with locally advanced and/or distant disease at the time of diagnosis. Whenever possible, these patients should be offered total thyroidectomy and radioiodine remnant ablation; howe...
Autores principales: | Dujovne, Noelia Vanesa, Gazek, Natalia, Pitoia, Fabian, Ayarzabal, Victor, Lucero, Maria Belen, Felipe, Laura, Ciaccio, Marta, Marti, Jessica Lopez, Herzovich, Viviana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207895/ http://dx.doi.org/10.1210/jendso/bvaa046.121 |
Ejemplares similares
-
MON-455 Papillary Thyroid Carcinoma in the Thyroglossal Duct
por: Franco, Katty Manrique, et al.
Publicado: (2020) -
MON-456 Clinical Profile of Thyroid Papillary Microcarcinoma in Brazil
por: Diniz, Bruna Dellatorre, et al.
Publicado: (2020) -
MON-486 Polygenic Susceptibility to Papillary Thyroid Cancer in Italian Subjects
por: Brigante, Giulia, et al.
Publicado: (2020) -
MON-521 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib (LEN) for the Treatment of Anaplastic Thyroid Cancer (ATC)
por: Wirth, Lori J, et al.
Publicado: (2020) -
MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma
por: Wofford, Wyatt O, et al.
Publicado: (2020)